Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.440
+0.010 (0.41%)
At close: Nov 20, 2024, 4:00 PM
2.360
-0.080 (-3.28%)
After-hours: Nov 20, 2024, 4:56 PM EST
Palisade Bio Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Palisade Bio stock has a target of 8.00, which predicts an increase of 227.87% from the current stock price of 2.44.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Palisade Bio is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $23 → $8 | Strong Buy | Maintains | $23 → $8 | +227.87% | Nov 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +822.13% | May 1, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +822.13% | Apr 16, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $23 | Hold → Strong Buy | Upgrades | $23 | +822.13% | Nov 17, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $375 → $240 | Strong Buy | Maintains | $375 → $240 | +9,736.07% | May 16, 2023 |
Financial Forecast
Revenue This Year
n/a
from 250.00K
Revenue Next Year
n/a
EPS This Year
-13.60
from -27.01
EPS Next Year
-9.30
from -13.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -13.76 | -4.33 | -3.91 | ||
| Avg | -13.60 | -9.30 | -10.08 | ||
| Low | -13.28 | -13.83 | -15.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.